APA

Rose T., Szelinski F., Lisney A., Reiter K., Fleischer S. J., Burmester G. R., Radbruch A., Hiepe F., Grützkau A., Biesen R. & Dörner T. (2016). SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. : RMD open.

Chicago

Rose Thomas, Szelinski Franziska, Lisney Anna, Reiter Karin, Fleischer Sarah J, Burmester Gerd R, Radbruch Andreas, Hiepe Falk, Grützkau Andreas, Biesen Robert and Dörner Thomas. 2016. SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. : RMD open.

Harvard

Rose T., Szelinski F., Lisney A., Reiter K., Fleischer S. J., Burmester G. R., Radbruch A., Hiepe F., Grützkau A., Biesen R. and Dörner T. (2016). SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. : RMD open.

MLA

Rose Thomas, Szelinski Franziska, Lisney Anna, Reiter Karin, Fleischer Sarah J, Burmester Gerd R, Radbruch Andreas, Hiepe Falk, Grützkau Andreas, Biesen Robert and Dörner Thomas. SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome. : RMD open. 2016.